Lipoprotein (a) levels in centenarians

Archives of Gerontology and Geriatrics

Volumn 22, Issue SUPPL.1, 1996, Pages 385-388

  Malaguarnera, M ^a   Ruello, P ^a   Rizzo, M ^a   Receputo, G ^a   Rapisarda, R ^a   Restuccia, N ^a   Pistone, G ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Cardio cerebrovascular risks; Centenarians; Serum lipoprotein(a)

Indexed keywords

LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN;

AGED; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 0029813842     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-4943(96)86967-6     Document Type: Article

References (13)

1. Albers, J.J., Adolphson, J.L. and Hazzard, W. R. (1977): Standardization of immunochemical quantitation of human plasma Lp(a). J. Lipid Res., 18, 331-332.
2. Bottinger, L.E. and Carlson, L.A. (1980): Risk factors for ischemic vascular death for men in the Stockholm Prospective Study. Atherosclerosis, 36, 389-394.
3. Brown, M.S. and Goldstein, J.L. (1991): The hyperlipoproteinemias and other disorders of lipid metabolism. In: X. Wilson, J. Braunwald, A.M. Isselbacher, N. Petersdorf, P. Martin, C. Fauci and M. Root (editors): Harrison's Principles of Internal Medicine. 12th edition, pp.: 1814-1825. McGraw-Hill Inc., New York.
4. Capurso, A., Colacicco, A.M., Resta, F., Vespertino, E., Fulgido, M. L., D'Amelio, M.C. and Venezia, A. (1994): Serum Lp(a) is high in healthy centenarians. In: Book of Abstracts of the 3rd International Symposium: Multiple Risk Factors in Cardiovascular Disease. Vascular and Organ Protection. Abstr. No. 39, Florence, Italy, July 1994.
5. o Congresso Italiano di Medicina Interna, I, pp.: 3-99 (in Italian).
6. Friedwald, W.T., Levi, R.I. and Frederickson, D.S. (1972): Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18, 499-502.
7. Gordon, T., Castelli, W.P., Marthana, C., Kannel, W.B. and Levy, D. (1977): Predicting coronary heart disease in middle-aged and older persons. The Framingham Study. J. Amer. Med. Assoc., 238, 497-502.
8. Krempler, F., Kostner, G.M., Bolzano, K. and Sandhofer, F. (1979): Lipoprotein(a) is not a metabolic product of other lipoproteins containing apolipoprotein B. Biochim. Biophys. Acta, 575, 63-67.
9. Mbewn, A.D. and Durrington, P.N. (1990): Lipoprotein(a) : structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis, 85, 1-14.
10. Miller, N.E. (1990): Aging and plasma lipoproteins. In: W.R. Hazzard, R. Andreas, E.L. Bierman and J.P. Blass (editors): Diseases of the Organ Systems. 2nd edition, pp.: 767-776. McGraw-Hill Inc., New York.
11. Ordovas, J.M., Peterson, J.P., Santaniello, P., Cohn, J.S., Wilson, P.W.F. and Schaefer, E.J. (1987): Enzyme linked immunosorbent assay for human plasma apolipoprotein B. J. Lipid Res., 28, 1216-1224.
12. Sandhalzer, C., Saha, N., Kark, J.D., Rees, A. Jaross, W., Dieplinger, H., Hopplicher, F., Boerwinkle, E. and Ultermann, G. (1992): Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Atheroscler. Thromb., 12, 1214-1226.
13. Schaefer, E.J. and Ordovas, J.M. (1986): Metabolism of apolipoproteins A-I, A-II and A-IV. Methods in Enzymol., 129, 440-443.